Market News How it works Learn FAQ
| GPUS 0.1689 34.05% | XXII 0.1977 -8.34% | SHFS 0.1324 -61.39% | NVD 4.19 0.96% | LUCD 0.411 25.42% | SPCX 147.49 1.89% | T 20.93 -7.96% | SOXL 83.56 1.77% | NU 15.16 2.92% | NOK 8.14 3.30% | EWZ 42.59 1.77% | NVDA 210.96 -0.59% | RIME 0.106 -12.90% | INTC 86.96 1.72% | TSLG 4.87 -1.62% | AAL 12.11 -3.89% | BBD 4.07 3.04% | STLA 4.06 -4.81% | SOXS 52.46 -1.85% | RWM 14.55 0.34% | HYG 77.05 -0.06% | MYND 0.24 47.42% | BITO 10.83 -0.28% | SPDN 8.54 0.47% | YFOR 0.2236 -1.58% | RBNE 0.19 -2.56% | TQQQ 66.29 -0.20% | VZ 44.66 -1.19% | TSLL 9.76 -1.21% | SPTI 27.63 -0.11% | YMAT 2.05 6.77% | CRWV 54.235 -2.46% | INFY 12.35 -6.58% | RIG 6.41 5.43% | F 11.6 -2.85% | SQQQ 39.68 0.20% | AIOK 12.02 182.82% | ONDS 6.2 2.99% | AAPL 347.725 -0.14% | LABT 0.31 -36.67% | CDE 13.45 -3.10% | PCG 12.63 -2.70% | GRAB 2.79 -2.11% | SOFI 14.615 -1.05% | XLE 69.33 2.60% | IREN 24.905 -2.37% | QID 14.55 0.14% | RKT 11.73 -0.09% | WULF 11.32 0.00% | BE 193.3 -11.24%
NVNovartis AG logo

Novartis AG (NVS)

New York Stock Exchange · Currency in USD
$151.12 ▼ -5.15 (-3.30%)
At close: Oct 23, 4:00 PM ET. Market closed.
$151.50 ▲ +0.38 (+0.25%)
After hours: Oct 23, 4:45 PM ET

Summary

Previous Close
$156.27
Open
$156.08
Day's Range
$149.18 – $156.08
52 Week Range
$121.57 – $170.46
Volume
4,358,785
Avg. Volume
2,027,542
Market Cap
$287.24B
Beta (5Y Monthly)
0.42
PE Ratio (TTM)
23.57
EPS (TTM)
$6.64
Earnings Date
Oct 27, 2026
Forward Dividend & Yield
$4.74 (3.14%)
Ex-Dividend Date
Mar 11, 2026
1y Target Est
$146.00

Profile: Novartis AG

Sector
Healthcare
Industry
Drug Manufacturers - General
Full-time employees
75,267
CEO
Vasant Narasimhan

Novartis AG is a holding company, which engages in the business of developing, manufacturing, and marketing healthcare products. Its product portfolio is heavily focused on innovative prescription medicines, especially oncology, immunology, neuroscience, and cardiovascular diseases, supplemented by established older brands and a wide range of specialized therapies. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.

Earnings

Next report: Tue, Oct 27, 2026
EPS estimate $2.25 · Revenue est. $14.53B
DateEst.Actual
Jul 21, 2026$2.17$2.41Beat
Apr 28, 2026$2.11$1.99Miss
Feb 4, 2026$1.99$2.03Beat
Oct 28, 2025$2.26$2.25Miss
Jul 17, 2025$2.38$2.42Beat
Apr 29, 2025$2.12$2.28Beat

Analyst view

Consensus price target
$146.00 ▼ -3.4%
Range $136.00 – $156.00
Rating: Hold
Buy 24% · Hold 68% · Sell 8%

Get free alerts on NVS and big market moves

Free special alerts by text & email on new investment opportunities, buyouts and the stocks moving most, in plain English.
Get free stock alerts →
Data: Financial Modeling Prep. For information only, not investment advice.